Bacterial Infections and Osteoclastogenesis Regulators in Men and Women with Cholesteatoma

Archivum Immunologiae et Therapiae Experimentalis

Volumn 64, Issue 3, 2016, Pages 241-247

  Likus, Wirginia ^a   Siemianowicz, Krzysztof ^a   Markowski, Jarosław ^a   Wiaderkiewicz, Jan ^a,b   Kostrząb Zdebel, Anna ^a   Jura Szołtys, Edyta ^a   Dziubdziela, Włodzimierz ^c   Wiaderkiewicz, Ryszard ^a   Łos, Marek J ^d,e  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c Outpatient Clinic for Treatment of Chronic Pain   (Poland)

^d LINKÖPING UNIVERSITY   (Sweden)

^e POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Bacterial infection; Cholesteatoma; Osteoprotegerin; RANKL; Sexes

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFUROXIME; CIPROFLOXACIN; ENDOTOXIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TNFRSF11A PROTEIN, HUMAN; TNFRSF11B PROTEIN, HUMAN; TNFSF11 PROTEIN, HUMAN;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS; BACTERIAL INFECTION; BACTERIUM ISOLATE; BONE DESTRUCTION; CHOLESTEATOMA; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CORYNEBACTERIUM; ESCHERICHIA COLI; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE EAR; MORGANELLA MORGANII; MYCOSIS; OSTEOCLASTOGENESIS; PROTEIN EXPRESSION; PROTEUS MIRABILIS; PROTEUS PENNERI; PSEUDOMONAS AERUGINOSA; SEX RATIO; STAPHYLOCOCCUS AUREUS; BONE; BONE DEVELOPMENT; COMPLICATION; GENE EXPRESSION REGULATION; INFLAMMATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; OSTEOCLAST; PHYSIOLOGY; PILOT STUDY;

ADULT; BACTERIAL INFECTIONS; BONE AND BONES; CHOLESTEATOMA; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; OSTEOCLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; PILOT PROJECTS; PSEUDOMONAS AERUGINOSA; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; STAPHYLOCOCCUS AUREUS;

EID: 84947561904     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-015-0373-7     Document Type: Article

References (28)

1. Bassiouny M, Badour N, Omran A et al (2012) Histopathological and immunohistochemical characteristics of acquired cholesteatoma in children and adults. Egyptian J Ear Nose Throat Allied Sci 13:7–12
2. Baud’huin M, Lamoureux F, Duplomb L et al (2007) RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases. Cell Mol Life Sci 64:2334–2350
3. Boyce F, Boyce MD, Xing L (2008) Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 473:139–146
4. Chaabane W, User SD, El-Gazzah M et al (2013) Autophagy, apoptosis, mitoptosis and necrosis—interdependence between those pathways and effects on cancer. Arch Immunol Ther Exp 61:43–58
5. Chaabane W, Cieślar-Pobuda A, El-Gazzah M et al (2014) Human-gyrovirus-apoptin triggers mitochondrial death pathway—Nur77 is required for apoptosis triggering. Neoplasia 16:679–693
6. Chole RA, Faddis BT (2002) Evidence for microbial biofilms in cholesteatoma. Arch Otolaryngol Head Neck Surg 128:1129–1133
7. Effat KG, Madany NM (2014) Mycological study on cholesteatoma keratin obtained during primary mastoid surgery. J Laryngol Otol 128:881–884
8. Haruyama T, Furukawa M, Kusunoki T et al (2010) Expression of IL-17 and its role in bone destruction in human middle ear cholesteatoma. ORL J Otorhinolaryngol Relat Spec 72:325–331
9. Jain MV, Paczulla AM, Dimgba FN et al (2013) Interconnections between apoptotic, autophagic and necrotic pathways: implications for cancer therapy development. J Cell Mol Med 17:12–29
10. Jangamreddy JR, Ghavami S, Grabarek J et al (2013) Salinomycin induced activation of autophagy, mitophagy, and affects mitochondrial polarity: differences between primary, and cancer cells. Biochim Biophys Acta 1833:2057–2069
11. Jeong JH, Park CW, Tae K et al (2006) Expression of RANKL and OPG in middle ear cholesteatoma tissue. Laryngoscope 116:1180–1184
12. Jung JY, Lee DH, Wang EW et al (2011) P. aeruginosa infection increases morbidity in experimental cholesteatomas. Laryngoscope 121:2449–2454
13. Kaya E, Dag I, Incesulu A et al (2013) Investigation of the presence of biofilms in chronic suppurative otitis media, nonsuppurative otitis media, and chronic otitis media with cholesteatoma by scanning electron microscopy. Sci World J 2013:638715
14. Kuczkowski J, Kobierska-Gulida G, Iżycka-Świeszewska E et al (2010a) [Molecular control of bone resorption in chronic otitis media with cholesteatoma] (article in Polish). Otolaryngol Pol 64:219–224
15. Kuczkowski J, Sakowicz-Birkiewicz M, Iżycka-Świeszewska E (2010b) Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media. Am J Otolaryngol 31:404–409
16. Lampikoski H, Aarnisalo AA, Jero J et al (2012) Mastoid biofilm in chronic otitis media with effusion. Otol Neurotol 33:785–788
17. Ma Y, Ye S (2008) [The expression of receptor activator nuclear factor-kappaB ligand and osteoprotegerin in cholesteatoma] (article in Chinese). Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 22:293–295
18. Madana J, Yolmo D, Kalaiarasi R et al (2011) Microbiological profile with antibiotic sensitivity pattern of cholesteatomatous chronic suppurative otitis media among children. Int J Pediatr Otorhinolaryngol 75:1104–1108
19. Maniu A, Harabagiu O, Schrepler MP et al (2014) Molecular biology of cholesteatoma. Rom J Morphol Embryol 55:7–13
20. Mirza O, Varadarajan V, Youshani AS et al (2014) Escherichia coli positive infratentorial subdural empyema secondary to mastoiditis and underlying cholesteatoma. BMJ Case Rep (pii: bcr2014204498)
21. Prodanov D, Verstreken K (2012) Automated segmentation and morphometry of cell and tissue structures. Selected algorithms in image J. In: Schaller B (ed) Molecular Imaging. InTech, Rijeka
22. Rollano Peñaloza OM, Lewandowska M, Stetefeld J et al (2014) Apoptins: selective anticancer agents. Trends Mol Med 20:519–528
23. Schindelin J, Arganda-Carreras I, Frise E et al (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676–682
24. Si Y, Chen YB, Chen QX et al (2013) Autologous meatal skin graft implantation and intratympanic injection of Pseudomona aeruginosa: a new experimental mouse model of acquired middle ear cholesteatoma. ORL J Otorhinolaryngol Relat Spec 75:274–281
25. Vitovski S, Philips JS, Sayers J et al (2007) Investigating the interaction between osteoprotegerin and receptor activator of NF-κB or tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 282:31601–31609
26. Wasik AM, Grabarek J, Pantovic A et al (2014) Reprogramming and carcinogenesis–parallels and distinctions. Int Rev Cell Mol Biol 308:167–203
27. Welkoborsky HJ (2011) [Current concepts of the pathogenesis of acquired middle ear cholesteatoma] (article in German). Laryngorhinootologie 90:38–48
28. Xia M, Ding S, Zhang H et al (2007) [Expression and significance of nuclear factor-kappa B ligand and correlation factor in the tissue of otitis media with cholesteatoma] (article in Chinese). Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 21:315–317